Answers are grounded in this paper and cite their sources.
As compared with the standard regimen of cisplatin and fluorouracil, induction chemotherapy with the addition of docetaxel significantly improved progression-free and overall survival in patients with unresectable squamous-cell carcinoma of the head and neck. (ClinicalTrials.gov number, NCT00003888 [ClinicalTrials.gov].).
No takes yet. Share an insight, caveat, or question.
Vermorken et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: